HARLOW: This morning, new hope in the fight against coronavirus, according to a trial out of Chicago. The University of Chicago, some patients severely infected with COVID-19 are recovering quickly after taking a drug called remdesivir. That report says that most people who have taken it are going home within days. The drug was originally tested against Ebola with little success, but now several studies in animals show it could prove both prevent and treat viruses related to COVID. That includes other respiratory illnesses like SARS and MERS, it is a drug from Gilead Sciences. They're expecting results from their own trial later this month. Joining me now to talk about all this is Dr. Leila Hojat; she's an infectious disease physician at University Hospitals Cleveland Medical Center and a principal investigator on this Gilead study. Nice to have you, thanks for joining me.</s>LEILA HOJAT, INFECTIOUS DISEASE PHYSICIAN, UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER: Thanks.</s>HARLOW: I've been hearing a lot about remdesivir for a few weeks now. And it certainly hasn't gotten the headlines that hydroxychloroquine has. But it looks like at least the University of Chicago study here pretty promising. What are you seeing?</s>HOJAT: Well, so we've had a lot of our patients improving and going home, and I think that we're all really pleased to see that. It's hard to know at this point if that's related to the study drug or not, but we're expecting results as you said a little bit later this month, at least on the first several hundred patients that were studied.</s>HARLOW: Yes, this is a big -- it's a broad trial that Gilead is doing. They're sponsoring tests, you're part of this.
Report: Remdesivir Drug Shows Promise as Coronavirus Treatment.